This is not the most recent version of the article. View current version (25 MAR 2017)

Intervention Protocol

You have free access to this content

Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility

  1. Alkistis Skalkidou1,*,
  2. Theodoros N Sergentanis2,
  3. Evangelos Evangelou3,
  4. Theodora Psaltopoulou2,
  5. Marianthi Sotiraki2,
  6. Marialena Trivella4,
  7. Charalampos S Siristatidis5,
  8. Eleni Petridou2

Editorial Group: Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group

Published Online: 17 JAN 2014

DOI: 10.1002/14651858.CD010931


How to Cite

Skalkidou A, Sergentanis TN, Evangelou E, Psaltopoulou T, Sotiraki M, Trivella M, Siristatidis CS, Petridou E. Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010931. DOI: 10.1002/14651858.CD010931.

Author Information

  1. 1

    Uppsala University, Department of Women's and Children's Health, Uppsala, Sweden

  2. 2

    School of Medicine, Department of Hygiene, Epidemiology and Medical Statistics, Athens, Greece

  3. 3

    University of Ioannina Medical School, Department of Hygiene and Epidemiology, Ioannina, Greece

  4. 4

    The Cochrane Collaboration, Cochrane Editorial Unit, Oxford, UK

  5. 5

    University of Athens, Assisted Reproduction Unit, 3rd Department of Obstetrics and Gynaecology, Athens, Chaidari, Greece

*Alkistis Skalkidou, Department of Women's and Children's Health, Uppsala University, Kvinnokliniken, Akademiska Sjukhuset, Uppsala, 75185, Sweden. alkistis.skalkidou@kbh.uu.se.

Publication History

  1. Publication Status: New
  2. Published Online: 17 JAN 2014

SEARCH

This is not the most recent version of the article. View current version (25 MAR 2017)

References

Additional references

  1. Additional references
  2. References to other published versions of this review
Adami 2008
  • Adami HO, Hunter D, Trichopoulos D. Textbook of Cancer Epidemiology. New York: Oxford University Press, 2008.
Akhmedkhanov 2001
Alder 2006
  • Alder N,  Fenty J,  Warren F,  Sutton AJ,  Rushton L,  Jones DR,  et al. Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. American Journal of Epidemiology 2006;164(5):405-20.
ASRM 2013
  • Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility 2013;99(1):63. [PUBMED: 23095139]
Ayhan 2004
Brown 2009
  • Brown J, Farquhar C, Beck J, Boothroyd C, Hughes E. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane Database of Systematic Reviews 2009;4:CD002249.
Cetin 2008
Chambers 2007
  • Chambers GM, Chapman MG, Grayson N, Shanahan M, Sullivan EA. Babies born after ART treatment cost more than non-ART babies: a cost analysis of inpatient birth-admission costs of singleton and multiple gestation pregnancies. Human Reproduction 2007;22(12):3108-15.
Chambers 2013
  • Chambers GM, Hoang VP, Illingworth PJ. Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs. Human Reproduction 2013;28(11):3111-7.
DerSimonian 1986
DH 2009
  • Expert Group on Commissioning NHS Infertility Provision. Regulated fertility services: a commissioning aid. www.dh.gov.uk/publications (accessed 18 June 2009).
Dhaliwal 2011
  • Dhaliwal LK, Suri V, Gupta KR, Sahdev S. Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome. Journal of Human Reproductive Sciences 2011;4(2):76-9.
Dickey 1996
Egger 1997
Fritz 2010
  • Fritz M, Speroff L. Clinical Gynecologic Endocrinology and Infertility. Baltimore: Lippincott Williams & Wilkins, 2010.
Goldstein 2000
Harbord 2006
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, www.cochrane-handbook.org.
Jensen 2009
  • Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. American Journal of Epidemiology 2009;170(11):1408-14.
Klip 2000
Larsson 2007
Li 2013
  • Li LL, Zhou J, Qian XJ, Chen YD. Meta-analysis on the possible association between in vitro fertilization and cancer risk. International Journal of Gynecological Cancer 2013;23(1):16-24. [PUBMED: 23211423]
Miannay 1994
  • Miannay E, Boutemy JJ, Leroy-Billiard M, Gasnault JP, Leroy JL. [The possible endometrial risk of ovarian stimulation. A propos of 3 cases] [Du risque endometrial de la stimulation ovarienne. A propos de trois cas]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1994;23(1):35-8. [PUBMED: 8157888]
Nakamura 1997
  • Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H. Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertility and Sterility 1997;67(2):256-60. [PUBMED: 9022599]
NICE 2004
  • National Collaborating Centre for Women’s and Children’s Health (UK). Fertility: assessment and treatment for people with fertility problems. London, UK: RCOG Press, 2004. [PUBMED: 21089236]
Rizzuto 2013
  • Rizzuto I, Larsen-Disney P, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database of Systematic Reviews 2013;8:CD008215.
Siristatidis 2013
  • Siristatidis C,  Sergentanis TN,  Kanavidis P,  Trivella M,  Sotiraki M,  Mavromatis I,  et al. Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer— a systematic review and meta-analysis. Human Reproduction Update 2013;19(2):105-23.
Sovino 2002
  • Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation induction. Reproductive BioMedicine Online 2002;4(3):303-10.
Steiner 2005
Swerdlow 2005
  • Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Journal of the National Cancer Institute 2005;97(5):375-84.
UpToDate 2013
  • Kuohung W, Hornstein MD. Overview of infertility. http://www.uptodate.com/contents/overview-of-infertility?detectedLanguage=en&source=search_result&search=overview+of+infertility&selectedTitle=1%7E150&provider=noProvider (assessed 28 June 2013).
Venn 1999
Wells 2011
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa: Ottawa, Canada.http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm (accessed on Jan 1, 2014).
Zegers-Hochschild 2009
  • Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O, Mansour R, Nygren K, et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertility and Sterility 2009; Vol. 92, issue 5:1520-4. [PUBMED: 19828144]

References to other published versions of this review

  1. Additional references
  2. References to other published versions of this review
Review Manager 2011 [Computer program]
  • Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.